Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines

被引:226
作者
Fong, WG
Liston, P
Rajcan-Separovic, E
St Jean, M
Craig, C
Korneluk, RG
机构
[1] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada
[2] Ottawa Reg Canc Ctr, Canc Res Grp, Ottawa, ON K1H 8L6, Canada
[3] British Columbia Women & Childrens Hosp, Vancouver, BC V6H 3V4, Canada
[4] Aegera Therapeut Inc, Ottawa, ON K1H 8M5, Canada
基金
英国医学研究理事会;
关键词
D O I
10.1006/geno.2000.6364
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
X-linked inhibitor of apoptosis protein (XIAP) is a potent modulator of programmed cell death. XIAP specifically binds and inhibits the function of caspase-3, -7, and -9, key effector proteases of apoptosis. We recently isolated, by yeast two-hybrid screening, a novel 34-kDa zinc finger protein, XIAP-associated factor 1 (XAF1). Both the caspase inhibiting and the anti-apoptotic abilities of XIAP were found to be blocked by overexpressed XAF1. Here, we report the isolation and characterization of the human XAF1 gene. The xaf1 gene consists of seven exons spanning 18 kb. Fluorescence in situ hybridization analysis localized the xaf1 locus at 17p13.2, telomeric to the p53 gene. The xaf1 locus was further refined to YAC 746C10, approximately 3 cM distal to TP53. Microsatellite analysis of the xaf1 locus using the NCI60 cell line panel revealed significantly decreased heterozygosity at all three polymorphic markers tested, suggesting that allelic loss of the xaf1 gene is prevalent in cancer cell lines. Examination of the same NCI cell line panel for xaf1 RNA expression demonstrated that cancer cell lines exhibited very low levels of mRNA relative to normal human liver. In contrast, XIAP mRNA levels were relatively high in the majority of cancer cell lines tested. We propose that a high level of XIAP to XAF1 expression in cancer cells may provide a survival advantage through the relative increase of XIAP anti-apoptotic function. (C) 2000 Academic Press.
引用
收藏
页码:113 / 122
页数:10
相关论文
共 36 条
  • [1] FUNCTIONAL EVIDENCE FOR A BREAST-CANCER GROWTH SUPPRESSOR GENE ON CHROMOSOME-17
    CASEY, G
    PLUMMER, S
    HOELTGE, G
    SCANLON, D
    FASCHING, C
    STANBRIDGE, EJ
    [J]. HUMAN MOLECULAR GENETICS, 1993, 2 (11) : 1921 - 1927
  • [2] CLEM RJ, 1998, GENE DEV, V13, P239
  • [3] CORNELIS RS, 1994, CANCER RES, V54, P4200
  • [4] X-linked IAP is a direct inhibitor of cell-death proteases
    Deveraux, QL
    Takahashi, R
    Salvesen, GS
    Reed, JC
    [J]. NATURE, 1997, 388 (6639) : 300 - 304
  • [5] IAP family proteins - suppressors of apoptosis
    Deveraux, QL
    Reed, TC
    [J]. GENES & DEVELOPMENT, 1999, 13 (03) : 239 - 252
  • [6] Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases
    Deveraux, QL
    Leo, E
    Stennicke, HR
    Welsh, K
    Salvesen, GS
    Reed, JC
    [J]. EMBO JOURNAL, 1999, 18 (19) : 5242 - 5251
  • [7] IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases
    Deveraux, QL
    Roy, N
    Stennicke, HR
    Van Arsdale, T
    Zhou, Q
    Srinivasula, SM
    Alnemri, ES
    Salvesen, GS
    Reed, JC
    [J]. EMBO JOURNAL, 1998, 17 (08) : 2215 - 2223
  • [8] A comprehensive genetic map of the human genome based on 5,264 microsatellites
    Dib, C
    Faure, S
    Fizames, C
    Samson, D
    Drouot, N
    Vignal, A
    Millasseau, P
    Marc, S
    Hazan, J
    Seboun, E
    Lathrop, M
    Gyapay, G
    Morissette, J
    Weissenbach, J
    [J]. NATURE, 1996, 380 (6570) : 152 - 154
  • [9] High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers
    Eiriksdottir, G
    Barkardottir, RB
    Agnarsson, BA
    Johannesdottir, G
    Olafsdottir, K
    Egilsson, V
    Ingvarsson, S
    [J]. ONCOGENE, 1998, 16 (01) : 21 - 26
  • [10] Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer
    Fujii, H
    Biel, MA
    Zhou, WB
    Weitzman, SA
    Baylin, SB
    Gabrielson, E
    [J]. ONCOGENE, 1998, 16 (16) : 2159 - 2164